HOME >> BIOLOGY >> NEWS
Two studies add to the growing evidence that green tea is beneficial for health, according to the

Bethesda -- Green tea contains high concentrations of antioxidants that have known protective effects. Green tea has received a lot of attention lately, as scientists begin to identify its benefits in warding off heart disease, cancer, obesity, and other illnesses.

Two new studies published in December 1999 add to the growing evidence that green tea is more than just a tasty beverage. The studies suggest that increasing consumption of green tea -- either through increased beverage intake or adding a dietary supplement to a healthy diet -- can trigger biochemical mechanisms that affect our health.

A study by Dulloo and Colleagues, published in the American Journal of Clinical Nutrition, found that green tea extract -- which contains high concentrations of antioxidants such as catechin-polyphenols and many other compounds including caffeine -- can increase the utilization of energy beyond the effects of caffeine alone. Consumption of green tea produced thermogenesis and increased energy expenditure and fat oxidation in humans.

A study by Erba and colleagues, published in the Journal of Nutrition, evaluated the effect of green tea compounds on oxidative damage caused by iron treatment in cultured human leukemia cells. Results showed that green tea protects cells from injury. Increasing intake of green tea may help reduce oxidative damage associated with various disease processes.

Says Sheri Zidenberg-Cherr, PhD, a representative of the Public Information Committee of The American Society for Nutritional Sciences and The American Society for Clinical Nutrition, "This is exciting news for the health and nutrition community. As scientists identify specific components in foods and beverages that affect human physiology, we gain an understanding of the function of foods beyond meeting known nutrient requirements and providing energy."

Today, scientists create "functional foods" by modifying
'"/>

Contact: Sheri Zidenberg-Cherr, PhD
sazidenbergcherr@ucdavis.edu
530-752-3817
American Society for Clinical Nutrition/American Society for Nutritional Sciences
13-Dec-1999


Page: 1 2

Related biology news :

1. Rensselaer marks the opening of the center for biotechnology and interdisciplinary studies
2. UCSD undergraduates participate in collaborative studies abroad on cyberinfrastructure
3. Scientist honored for studies of genetic influence on chemotherapy, tumor development
4. $5 million grant funds partnership, studies of minority-based issues in reproductive health
5. Synthetic hormone used in contraceptives and HRT produces negative effects in monkey studies
6. $5.5 million awarded to tree-ring research and climate studies
7. Pancreatic cancer blood test & gene studies show promise
8. Two studies weigh in on low-carb diets
9. Animal studies show promise treating severe chronic pain
10. New studies show Curves Program raises metabolic rate in overweight and sedentary women
11. Florida Tech researchers win $912,700 grant for cell studies

Post Your Comments:
(Date:5/21/2013)... at USC have found that a class of pharmaceuticals ... , The drugs, known as "TSPO ligands," are ... looked at the effects of TSPO ligand in young ... and in aged mice when pathology was quite severe," ... School of Gerontology. "TSPO ligand reduced measures of pathology ...
(Date:5/21/2013)... Michigan Water Center today awarded 12 research grants, ... and protection efforts. , The two-year grants of ... efforts to track the remediation of harmful algae ... non-native weedy plant invasions; study chromosomal damage in ... restoration activities. , The grants were awarded to ...
(Date:5/21/2013)... an uphill battle? Try staying fit in space, where ... and bone. , That,s the challenge a group of ... three-year, $1.2 million grant from NASA. Their goal is ... missions. , "You could give astronauts the best exercise ... to stick to it, it isn,t going to help," ...
Breaking Biology News(10 mins):Drugs found to both prevent and treat Alzheimer's disease in mice 2U-M Water Center awards $570K in Great Lakes restoration grants 2U-M Water Center awards $570K in Great Lakes restoration grants 3U-M Water Center awards $570K in Great Lakes restoration grants 4Fueling fitness on the final frontier 2
(Date:5/22/2013)... Express Diagnostics Int’l, Inc. (EDI) , ... pleased to announce a sponsorship agreement with Erebus Motorsport ... distributor of DrugCheck® onsite testing devices, manufactured by EDI. ... Austin 400 May 17-19 in Austin, Texas. , Royal ... each car of the Erebus Motorsport team displaying the ...
(Date:5/22/2013)... Chester, PA (PRWEB) May 22, 2013 ... company as Fermentation Manager. Mr. McErlean has an ... variety of leadership positions throughout his career. ... “We are very pleased to have Mike join our ... newly installed large scale fermentation and downstream ...
(Date:5/22/2013)... 22, 2013 The ability to ... the information they encode. There are now a ... sequencing of ribosome protected fragments) that dramatically expand ... Keynote speakers include Dr. Jonathan Weissman, an Investigator ... Howard Hughes Medical Institute, who will present recent ...
(Date:5/21/2013)... 22, 2013 First patients dosed ... glycopyrronium bromide designed using Prosonix, particle engineering platform ... portfolio of inhaled Respiratory Medicines by Design , ... that will assess its effect on lung function and ... with moderate to severe chronic obstructive pulmonary disease (COPD). ...
Breaking Biology Technology:Australian Distributor of Express Diagnostics Signs Sponsorship Agreement with V8 Supercar Team 2Envera Appoints Michael McErlean Fermentation Manager 2Monitoring Protein Synthesis One Codon at a Time Through Ribosome Profiling, a Webinar Hosted by Xtalks 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4
Cached News: